AAAAAA
Results:
1-18
|
Results: 18
Authors:
Becouarn, Y
Gamelin, E
Coudert, B
Negrier, S
Pierga, JY
Raoul, JL
Provencal, J
Rixe, O
Krisch, C
Germa, C
Bekradda, M
Mignard, D
Mousseau, M
Citation: Y. Becouarn et al., Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients, J CL ONCOL, 19(22), 2001, pp. 4195-4201
Authors:
Negrier, S
Fervers, B
Bailly, C
Beckendorf, V
Cupissol, D
Dore, JF
Dorval, T
Garbay, JR
Vilmer, C
Citation: S. Negrier et al., Cutaneous melanoma, BR J CANC, 84, 2001, pp. 81-85
Authors:
Negrier, S
Maral, J
Drevon, M
Vinke, J
Escudier, B
Philip, T
Citation: S. Negrier et al., Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe, CA J SCI AM, 6, 2000, pp. S93-S98
Authors:
Negrier, S
Citation: S. Negrier, On the guidelines for management of patients with cutaneous melanomas, PRESSE MED, 29(23), 2000, pp. 1295-1298
Authors:
Negrier, S
Fervers, B
Bailly, C
Beckendorf, V
Cupissol, D
Dore, JF
Garbay, JR
Vilmer, C
Borel, C
Boulier, N
Cabarrot, E
Carrie, C
Chevreau, C
de Cislain, C
Delaunay, MM
Depardieu, C
Dubois, JB
Escande, MC
Fraisse, J
Parache, RM
Philip, T
Ravaud, A
Sancho-Garnier, H
Spatz, A
Autier, P
Bonnetblanc, JM
de Raucourt, S
Dreno, B
Gouttebel, MC
Grange, F
Guillot, B
Khayat, D
Lehmann, M
Leroy, D
Regal, R
Revuz, J
Saiag, P
Schmutz, JL
Truchetet, F
Vuillemin, P
Citation: S. Negrier et al., Standards, options and guidelines for caring for patients with cutaneous melanomas, PRESSE MED, 29(23), 2000, pp. 1317-1326
Authors:
Negrier, S
Caty, A
Lesimple, T
Douillard, JY
Escudier, B
Rossi, JF
Viens, P
Gomez, F
Citation: S. Negrier et al., Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil, J CL ONCOL, 18(24), 2000, pp. 4009-4015
Authors:
Voog, E
Merrouche, Y
Trillet-Lenoir, V
Lasset, C
Peaud, PY
Rebattu, P
Negrier, S
Citation: E. Voog et al., Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primary, AM J CL ONC, 23(6), 2000, pp. 614-616
Authors:
Kurtz, JE
Kohser, F
Negrier, S
Trillet-Lenoir, V
Walter, S
Limacher, JM
Untereiner, M
Kayitalire, L
Jaeck, D
Dufour, P
Citation: Je. Kurtz et al., Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase IIstudy, HEP-GASTRO, 47(35), 2000, pp. 1450-1453
Authors:
Haicheur, N
Escudier, B
Dorval, T
Negrier, S
De Mulder, PHM
Dupuy, JM
Novick, D
Guillot, T
Wolf, S
Pouillart, P
Fridman, WH
Tartour, E
Citation: N. Haicheur et al., Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients, CLIN EXP IM, 119(1), 2000, pp. 28-37
Authors:
Negrier, S
Fervers, B
Bailly, C
Beckendorf, V
Cupissolv, D
Dore, JF
Dorval, T
Garbay, JR
Vilmer, C
Citation: S. Negrier et al., Standards, Options and Recommendations (SOR): clinical practice guidelinesfor diagnosis, treatment and follow-up of cutaneous melanoma, B CANCER, 87(2), 2000, pp. 173-182
Authors:
Negrier, S
Citation: S. Negrier, New guidelines for tumor response evaluation in oncology: try them!, B CANCER, 87(12), 2000, pp. 869-870
Authors:
Negrier, S
Ollivier, L
Di Stefano-Louineau, D
Escudier, B
Savary, J
Lasset, C
Thiesse, P
Citation: S. Negrier et al., Response rate accuracy in oncology - Analysis of causes for variation, B CANCER, 87(12), 2000, pp. 927-934
Authors:
Autier, P
Dore, JF
Negrier, S
Lienard, D
Panizzon, R
Lejeune, FJ
Guggisberg, D
Eggermont, AMM
Citation: P. Autier et al., Sunscreen use and duration of sun exposure: a double-blind, randomized trial, J NAT CANC, 91(15), 1999, pp. 1304-1309
Authors:
Escudier, B
Chevreau, C
Lasset, C
Douillard, JY
Ravaud, A
Fabbro, M
Caty, A
Rossi, JF
Viens, P
Bergerat, JP
Savary, J
Negrier, S
Citation: B. Escudier et al., Cytokines in metastatic renal cell carcinoma: Is it useful to switch to interleukin-2 or interferon after failure of a first treatment?, J CL ONCOL, 17(7), 1999, pp. 2039-2043
Authors:
Dorval, T
Negrier, S
Chevreau, C
Avril, MF
Baume, D
Cupissol, D
Oskam, R
de Peuter, R
Vinke, J
Herrera, L
Escudier, B
Citation: T. Dorval et al., Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma, CANCER, 85(5), 1999, pp. 1060-1066
Authors:
Kurtz, JE
Trillet-Lenoir, V
Bugat, R
Negrier, S
Adenis, A
Kayitalire, L
Ripoche, V
Dufour, P
Citation: Je. Kurtz et al., Compassionate use of gemcitabine in advanced pancreatic cancer: a French multicentric study, B CANCER, 86(2), 1999, pp. 202-206
Authors:
Negrier, S
Citation: S. Negrier, Cytokines and cancer: News in 1998, B CANCER, 86(1), 1999, pp. 37-39
Authors:
Philip, T
Negrier, S
Citation: T. Philip et S. Negrier, Report on 10 years of immunotherapy for the treatment of metastatic renal carcinoma, EUROCANCER 98, 1998, pp. 337-338
Risultati:
1-18
|